Long-lasting effects of a single subcutaneous dose of Ketamine for treating melancholic depression: A case report

Biological Psychiatry

Volumn 76, Issue 3, 2014, Pages

  Gálvez, Veronica ^a   O'Keefe, Emily ^a   Cotiga, Laura ^a   Leyden, John ^c   Harper, Simon ^a   Glue, Paul ^e   Mitchell, Philip B ^a   Somogyi, Andrew A ^d   Delory, Amanda ^b   Loo, Colleen K ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b WESLEY HOSPITAL   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHLORTALIDONE; DILTIAZEM; DOSULEPIN; DULOXETINE; FENOFIBRATE; IRBESARTAN; KETAMINE; LITHIUM; MIANSERIN; MIDAZOLAM; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; PLACEBO; QUETIAPINE; REBOXETINE; SERTRALINE; THYROXINE; VENLAFAXINE; VITAMIN D; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT;

ADULT; ANHEDONIA; BLURRED VISION; BRIEF PSYCHIATRIC RATING SCALE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CIRCADIAN RHYTHM; CLINICAL FEATURE; CLINICIAN ADMINISTERED DISSOCIATIVE SYMPTOMS SCALE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DEPRESSION; DISEASE ACTIVITY; DISEASE DURATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DSM-IV; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; GUILT; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INSOMNIA; LETTER; MAJOR DEPRESSION; MEDICAL HISTORY; MELANCHOLIA; MELANCHOLIC DEPRESSION; MOOD DISORDER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; MALE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MALE;

EID: 84904043755     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.12.010     Document Type: Letter

References (14)

1. N. Katalinic, R. Lai, A. Somogyi, P.B. Mitchell, P. Glue, and C.K. Loo Ketamine as a new treatment for depression: A review of its efficacy and adverse effects Aust N Z J Psychiatry 47 2013 710 727
2. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 2000 351 354
3. M. Aan Het Rot, C.A. Zarate Jr, D.S. Charney, and S.J. Mathew Ketamine for depression: Where do we go from here? Biol Psychiatry 72 2012 537 547
4. S.A. Irwin, A. Iglewicz, R.A. Nelesen, J.Y. Lo, C.H. Carr, and S.D. Romero et al. Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: A 28-day open-label proof-of-concept trial J Palliat Med 16 2013 958 965
5. J.P. McNulty, and K. Hahn Compounded oral ketamine Int J Pharm Compd 16 2012 364 368
6. G. Paslakis, M. Gilles, A. Meyer-Lindenberg, and M. Deuschle Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: A case series Pharmacopsychiatry 43 2010 33 35
7. P. Glue, A. Gulati, M. Le Nedelec, and S. Duffull Dose and exposure response to ketamine in depression Biol Psychiatry 70 2011 e9 e10 author reply e1-e2
8. C. Cusin, G.Q. Hilton, A.A. Nierenberg, and M. Fava Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression Am J Psychiatry 169 2012 868 869
9. C.G. Zanicotti, D. Perez, and P. Glue Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer J Palliat Med 15 2012 400 403
10. C. Harihar, P. Dasari, and J.S. Srinivas Intramuscular ketamine in acute depression: A report on two cases Indian J Psychiatry 55 2013 186 188
11. D.R. Lara, L.W. Bisol, and L.R. Munari Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression Int J Neuropsychopharmacol 16 2013 2111 2117
12. M.J. Javid, M. Rahimi, and A. Keshvari Dissociative conscious sedation, an alternative to general anesthesia for laparoscopic peritoneal dialysis catheter implantation: A randomized trial comparing intravenous and subcutaneous ketamine Perit Dial Int 31 2011 308 314
13. G.L. Larkin, and A.L. Beautrais A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department Int J Neuropsychopharmacol 14 2011 1127 1131
14. O.V. Atigari, and D. Healy Sustained antidepressant response to ketamine [published online ahead of print August 19] BMJ Case Rep 2013